Corbevax

Rediff.com » News » Corbevax

News for Corbevax

News
Business

Should Govt Continue Covid Vax Drive?

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

The move comes at a time when Omicron and its sub-variants have remained the dominant strains in circulation for close to two years now. Most of the vaccines available and administered in......

Does India have enough vaccine reserves to combat another Covid wave?

Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......

Covid vax didn't increase risk of sudden death among young: Govt

A study conducted by the Indian Council of Medical Research (ICMR) has observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, the......

Corbevax gets nod as booster dose after Covaxin, Covishield

The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. IMAGE: A healthcare worker inoculates......

Sensex, Nifty edge down on profit-booking in banking, metal stocks

SBI was the top loser in the Sensex pack, shedding over 1 per cent. ITC, NTPC, Tech Mahindra, Tata Steel, Kotak Bank and M&M were among major losers. Benchmark indices Sensex and Nifty retreated......

Sensex, Nifty race to over 1-week high amid global stock rally

As many as 28 of its constituents closed with gains while two declined. The broad-based Nifty of the National Stock Exchange rose by 147.20 points or 0.86 per cent to settle 17,233.45, tracking......

Rediff News

Corbevax

News for Corbevax

Should Govt Continue Covid Vax Drive?

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Does India have enough vaccine reserves to combat another Covid wave?

Covid vax didn't increase risk of sudden death among young: Govt

Corbevax gets nod as booster dose after Covaxin, Covishield

Sensex, Nifty edge down on profit-booking in banking, metal stocks

Sensex, Nifty race to over 1-week high amid global stock rally

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS